SG11202007869WA - Pharmaceutical combination preparation comprising ezetimibe and rosuvastatin - Google Patents
Pharmaceutical combination preparation comprising ezetimibe and rosuvastatinInfo
- Publication number
- SG11202007869WA SG11202007869WA SG11202007869WA SG11202007869WA SG11202007869WA SG 11202007869W A SG11202007869W A SG 11202007869WA SG 11202007869W A SG11202007869W A SG 11202007869WA SG 11202007869W A SG11202007869W A SG 11202007869WA SG 11202007869W A SG11202007869W A SG 11202007869WA
- Authority
- SG
- Singapore
- Prior art keywords
- ezetimibe
- rosuvastatin
- pharmaceutical combination
- combination preparation
- preparation
- Prior art date
Links
- OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 title 1
- 229960000815 ezetimibe Drugs 0.000 title 1
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 title 1
- 229960000672 rosuvastatin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020180031536A KR102569271B1 (en) | 2018-03-19 | 2018-03-19 | Pharmaceutical combination preparation comprising ezetimibe and rosuvastatin |
| PCT/KR2019/002769 WO2019182276A1 (en) | 2018-03-19 | 2019-03-11 | Pharmaceutical combination preparation comprising ezetimibe and rosuvastatin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202007869WA true SG11202007869WA (en) | 2020-09-29 |
Family
ID=67986281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202007869WA SG11202007869WA (en) | 2018-03-19 | 2019-03-11 | Pharmaceutical combination preparation comprising ezetimibe and rosuvastatin |
Country Status (10)
| Country | Link |
|---|---|
| KR (1) | KR102569271B1 (en) |
| CN (1) | CN111886003A (en) |
| CO (1) | CO2020010204A2 (en) |
| EA (1) | EA202092189A1 (en) |
| MX (1) | MX2020009492A (en) |
| PH (1) | PH12020500656A1 (en) |
| SG (1) | SG11202007869WA (en) |
| TW (1) | TW201944992A (en) |
| WO (1) | WO2019182276A1 (en) |
| ZA (1) | ZA202004982B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102500643B1 (en) * | 2019-04-18 | 2023-02-16 | 한미약품 주식회사 | Pharmaceutical combination preparation comprising ezetimibe and losartan |
| WO2021226561A1 (en) * | 2020-05-07 | 2021-11-11 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Covid-19 therapeutics and methods of treatment |
| GB2622822A (en) * | 2022-09-28 | 2024-04-03 | Novumgen Ltd | A rapidly disintegrating tablet of rosuvastatin and its process of preparation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009024889A2 (en) * | 2007-08-21 | 2009-02-26 | Ranbaxy Laboratories Limited | Pharmaceutical composition comprising a hmg-coa reductase inhibitor and ezetimibe |
| PT2844233T (en) * | 2012-05-01 | 2020-06-25 | Althera Life Sciences Llc | Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases |
| CN103585157B (en) * | 2013-11-13 | 2016-02-03 | 武汉武药科技有限公司 | A kind of double-layer tablet containing Ezetimibe and Rosuvastatin and preparation method thereof |
| KR101910901B1 (en) * | 2013-11-29 | 2018-10-24 | 한미약품 주식회사 | Pharmaceutical complex formulation comprising amlodipine, losartan and rosuvastatin |
| KR20150079373A (en) * | 2013-12-30 | 2015-07-08 | 한미약품 주식회사 | Composite formulation for oral administration comprising ezetimibe and rosuvastatin |
| EP3243506A1 (en) * | 2016-05-09 | 2017-11-15 | Adamed sp. z o.o. | Pharmaceutical composition |
-
2018
- 2018-03-19 KR KR1020180031536A patent/KR102569271B1/en active IP Right Grant
-
2019
- 2019-03-11 WO PCT/KR2019/002769 patent/WO2019182276A1/en active Application Filing
- 2019-03-11 MX MX2020009492A patent/MX2020009492A/en unknown
- 2019-03-11 CN CN201980020077.6A patent/CN111886003A/en active Pending
- 2019-03-11 SG SG11202007869WA patent/SG11202007869WA/en unknown
- 2019-03-11 EA EA202092189A patent/EA202092189A1/en unknown
- 2019-03-14 TW TW108108673A patent/TW201944992A/en unknown
-
2020
- 2020-08-12 ZA ZA2020/04982A patent/ZA202004982B/en unknown
- 2020-08-19 CO CONC2020/0010204A patent/CO2020010204A2/en unknown
- 2020-08-27 PH PH12020500656A patent/PH12020500656A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019182276A1 (en) | 2019-09-26 |
| CN111886003A (en) | 2020-11-03 |
| KR20190109892A (en) | 2019-09-27 |
| PH12020500656A1 (en) | 2021-06-21 |
| KR102569271B1 (en) | 2023-08-23 |
| ZA202004982B (en) | 2023-02-22 |
| CO2020010204A2 (en) | 2020-08-31 |
| MX2020009492A (en) | 2021-01-15 |
| EA202092189A1 (en) | 2020-12-14 |
| TW201944992A (en) | 2019-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284835A (en) | Pharmaceutical combination comprising tno155 and ribociclib | |
| IL290745A (en) | Pyrimidine compound and pharmaceutical use thereof | |
| ZA202004982B (en) | Pharmaceutical combination preparation comprising ezetimibe and rosuvastatin | |
| IL273339A (en) | Griseofulvin compound and pharmaceutical use thereof | |
| IL265172A (en) | A pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof | |
| GB201715194D0 (en) | Compounds and their therapeutic use | |
| IL276323A (en) | 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof | |
| IL276326A (en) | Saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds and pharmaceutical use thereof | |
| IL276311A (en) | Methyllactam ring compound and pharmaceutical use thereof | |
| EP3735277C0 (en) | Medical materials and devices | |
| IL278517A (en) | Azabenzimidazole compounds and pharmaceutical | |
| IL282142A (en) | 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament | |
| ZA202006346B (en) | Pharmaceutical preparation | |
| EP3597640A4 (en) | Novel benzimidazolone compound and pharmaceutical use thereof | |
| ZA202108268B (en) | Pharmaceutical combination preparation comprising ezetimibe and losartan | |
| IL292646A (en) | Pharmaceutical combination and use thereof | |
| GB201802743D0 (en) | Medicament and use thereof | |
| IL282157A (en) | Compounds and therapeutic uses thereof | |
| KR102483492B9 (en) | 25- 25-disubstituted pyrimidines and pharmaceutical composition comprising the same | |
| HK1254527A1 (en) | Pharmaceutical formulation and use thereof | |
| GB201718320D0 (en) | Therapeutic substances and their preparation | |
| GB201813312D0 (en) | Compounds and their therapeutic use |